Resistance to topoisomerase II poisons: Is the answer in the promoter?

Leukemia Research

Volumn 21, Issue 11-12, 1997, Pages 1033-1036

  Kaufmann, S H ^a  

^a MAYO CLINIC COLLEGE OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMSACRINE; ANTHRACYCLINE; DAUNORUBICIN; DNA TOPOISOMERASE (ATP HYDROLYSING); ETOPOSIDE; GYRASE INHIBITOR; MESSENGER RNA; TENIPOSIDE; TRANSCRIPTION FACTOR;

DRUG RESISTANCE; LEUKEMIA; PRIORITY JOURNAL; PROMOTER REGION; SHORT SURVEY; TRANSCRIPTION REGULATION;

EID: 0031438850     PISSN: 01452126     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0145-2126(97)00067-2     Document Type: Note

References (31)

1. T.L. Brandt D.J. Kroll NF-M transactivates the human DNA topoisomerase IIα promoter independently of c-MYB in HL-60 cells Leukemia Research 21 1997 711
2. N. Osheroff E.L. Zechiedrich K.C. Gale Catalytic function of DNA topoisomerase II Bioessays 13 1991 269
3. S.J. Froelich-Ammon N. Osheroff Topoisomerase poisons: harnessing the dark side of enzyme mechanism Journal of Biological Chemistry 270 1995 21429
4. P. Mesner I. Budihardjo S.H. Kaufmann Chemo-therapy-induced apoptosis Advances in Pharmacology 41 1997 461
5. A.Y. Chen L.F. Liu DNA topoisomerases: essential enzymes and lethal targets Annual Review of Pharmacology and Toxicology 34 1994 191
6. Y. Pommier F. Leteurtre M.R. Fesen A. Fujimori R. Bertrand E. Solary G. Kohlhagen K.W. Kohn Cellular determinants of sensitivity and resistance to DNA topoisomerase inhibitors Cancer Investigations 12 1994 530
7. J.L. Nitiss Using yeast to study resistance to topoisomerase II-targeting drugs Cancer Chemotherapy and Pharmacology 34S 1994 S6
8. M.M. Heck W.C. Earnshaw Topoisomerase II: a specific marker for cell proliferation Journal of Cell Biology 103 1986 2569
9. Y.H. Hsiang H.Y. Wu L.F. Liu Proliferation-dependent regulation of DNA topoisomerase II in cultured human cells Cancer Research 48 1988 3230
10. S.H. Kaufmann S.J. McLaughlin M. Kastan L.F. Liu J.E. Karp P.J. Burke Topoisomerase II levels during granulocytic maturation in vitro and in vivo Cancer Research 51 1991 3534
11. E. Prosperi C. Negri G. Marchese G.C.B. Astaldi Ricotti Expression of the 170 kDA and 180 kDA isoform of DNA topoisomerase II in resting and proliferating human lymphocytes Cell Proliferation 27 1994 257
12. F.H. Drake G.A. Hofmann H.F. Bartus M.R. Mattern S.T. Crooke C.K. Mirabelli Biochemical and pharmacological properties of p170 and p180 forms of topoisomerase II Biochemistry 28 1989 8154
13. M. Cornarotti S. Tinelli E. Willmore F. Zunino L.M. Fisher C.A. Austin G. Capranico Drug sensitivity and sequence specificity of human recombinant DNA topoisomerase IIα (p170) and IIβ (p180) Molecular Pharmacology 50 1996 1463
14. D. Hochhauser C.A. Stanway A.L. Harris I.D. Hickson Cloning and characterization of the 5′-flanking region of the human topoisomerase II alpha gene Journal of Biological Chemistry 267 1992 18961
15. M.I. Sandri R.J. Isaacs W.M. Ongkeko A.L. Harris I.D. Hickson M. Broggini F. Vikhanskaya p53 regulates the minimal promoter of the human topoisomerase IIα gene Nucleic Acids Research 24 1996 4464
16. Q. Wang G.P. Zambetti D.P. Suttle Inhibition of DNA topoisomerase IIα gene expression by the p53 tumor suppressor Molecular and Cellular Biology 17 1997 389
17. R.J. Isaacs A.L. Harris I.D. Hickson Regulation of the human topoisomerase IIα gene promoter in confluencearrested cells Journal of Biological Chemistry 271 1996 16741
18. D.J. Fraser T.L. Brandt D.J. Kroll Topoisomerase IIα promoter transactivation early in monocytic differentiation of HL-60 human leukemia cells Molecular Pharmacology 47 1995 696
19. T.L. Brandt D.J. Fraser S. Leal P.M. Halandras A.R. Kroll D.J. Kroll c-Myb trans -activates the human DNA topoisomerase IIα gene promoter Journal of Biological Chemistry 272 1997 6278
20. S. Katz E. Kowenz-Leutz C. Müller K. Meese S.A. Ness A. Leutz The NF-M transcription factor is related to C/EBP/b and plays a role in signal transduction, differentiation and leukemogenesis of avian myelomono-cytic cells EMBO Journal 12 1993 1321
21. S.A. Ness E. Kowenz-Leutz T. Casini T. Graf A. Leutz Myb and NF-M: combinatorial activators of myeloid genes in heterologous cell types Genes and Development 7 1993 749
22. S. McCracken S. Leung R. Bosselut J. Ghysdael N.G. Miyamoto Myb and Ets related transcription factors are required for activity of the human Lck type I promoter Oncogene 9 1994 3609
23. L.H. Shapiro Myb and Ets proteins cooperate to transactivate an early myeloid gene Journal of Biological Chemistry 270 1995 8763
24. L.G. Wang X.M. Liu Z.R. Li S. Denstman A. Bloch Differential binding of nuclear C-Ets-1 protein to an intron I fragment of the c-myb gene in growth versus differentiation Cell Growth and Differentiation 5 1994 1243
25. K.V. Chin K. Ueda I. Pastan M.M. Gottesman Modulation of activity of the promoter of the human MDR1 gene by Ras and p53 Science 255 1992 459
26. S. Benchimol V. Ling P-Glycoprotein and tumor progression Journal of the National Cancer Institute 86 1994 814
27. J. Beck R. Handgretinger R. Dopfer T. Klingebiel D. Niethammer V. Gekeler Expression of MDR1, MRP, topoisomerase II α β and cyclin A in primary or relapsed states of acute lymphoblastic leukemias British Journal of Haematology 89 1995 356
28. E. Klumper G. Giaccone R. Pieters G. Broekema J. van Ark-Otte E.R. van Wering G.J.L. Kaspers A.J.P. Veerman Topoisomerase IIα gene expression in childhood acute lymphoblastic leukemia Leukemia 9 1995 1653
29. J. Beck R. Handgretinger T. Klingebiel R. Dopfer M. Schaich G. Ehninger D. Niethammer V. Gekeler Expression of PKC isozyme and MDR-associated genes in primary and relapsed state AML Leukemia 10 1996 426
30. S.H. Kaufmann J.E. Karp R.J. Jones C.B. Miller E. Schneider L.A. Zwelling K. Cowan K. Wendel P.J. Burke Topoisomerase II levels and drug sensitivity in adult acute myelogenous leukemia Blood 83 1994 517
31. E. Solary R. Bertrand Y. Pommier Apoptosis induced by DNA topoisomerase I and II inhibitors in human leukemic HL-60 cells Leukemia and Lymphana 15 1994 21